ESTROFEM Price

Overview

Welcome to Dwaey, specifically on ESTROFEM Tablets/Film-coated page.
This medicine contains an important and useful components, as it consists of Estradiol.
ESTROFEM is available in the market in concentration 2mg/Tablet and in the form of Tablets/Film-coated.

NOVO NORDISK A/S is the producer of ESTROFEM and it is imported from DENMARK, The most popular alternatives of ESTROFEM are listed downward .

Mode Of Action

Estradiol is a naturally occurring oestrogen. Oestrogens are responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. They modulate the pituitary secretion of gonadotrophins, LH and FSH through a negative feedback system.

Indication

• Moderate to severe vasomotor symptoms associated with menopause
• Prophylaxis of osteoporosis in postmenopausal women
• Hypogonadism
• Atrophic vaginitis

Precaution

Conditions exacerbated by fluid retention; hypercalcaemia, cerebrovascular diorders, coronary artery disease, gall bladder diseases; lipid effects; familial defects of lipoprotein metabolism. May increase BP, risk of venous thromboembolism, breast cancer, benign hepatic adenoma, endometrial cancer and size of preexisting uterine leiomyomata. Dosage should be reduced in hepatic impairment. Lactation. Child. Lactation: Drug enters breast milk; use with caution

Side Effects

• Anxiety
• Abdominal cramping
• Amenorrhea
• Bloating
• Breakthrough bleeding
• Breast enlargement
• Breast tenderness
• Delayed ejaculation
• Depression
• Dry mouth
• Headache
• Hypertension
• Impotency
• Influenza
• Leukorrhea
• Melasma
• Muscle cramps
• Nausea
• Nervousness
• Peripheral edema
• Polydipsia
• Pruritus
• Rash
• Swelling
• Spotting
• Syncope
• Toothache
• Vaginal discomfort
• vaginal erosion
• vaginal ulceration
• adherence of the vaginal ring to the vaginal wall (Estring)
• Vomiting
• Weight changes

Contra indication

Hypersensitivity; undiagnosed vag bleeding; thrombophloebitis or thromboembolic disorders; breast carcinoma except in selected patients being treated for metastatic disease; oestrogen-dependent tumor; porphyria; pregnancy.

Pregnancy and lactation

Pregnancy category: X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.